Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/1995
11/23/1995CA2190262A1 Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof
11/23/1995CA2190253A1 Device and methods for in vivo culturing of diverse tissue cells
11/23/1995CA2190102A1 Human papilloma virus inhibition by a hairpin ribozyme
11/23/1995CA2189983A1 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors
11/23/1995CA2189975A1 Peptide-mediated gene transfer
11/23/1995CA2189761A1 Dna encoding the beta subunit of a mammalian "maxi-k" potassium channel
11/23/1995CA2189421A1 Collagen from cell cultures
11/23/1995CA2188562A1 Method of introducing pathogen resistance in plants
11/23/1995CA2188421A1 Alphavirus expression vector
11/22/1995EP0683234A1 ANTIBODY AGAINST $g(b)-AMYLOID OR DERIVATIVE THEREOF AND USE THEREOF
11/22/1995EP0683232A1 Process for producing taxane diterpene and method of harvesting cultred cell capable of producing taxane diterpene in high yield
11/22/1995EP0683226A1 Transgenic animals as a model for metabolic bone diseases
11/22/1995EP0682714A1 Novel neutrophil inhibitors
11/22/1995EP0682712A1 Human interferon expression vectors for treating aids
11/22/1995EP0682711A1 Plants resistant to infection by plrv
11/22/1995EP0682707A1 Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
11/22/1995EP0682705A1 Tnf-alpha muteins and a process for preparing them
11/22/1995EP0682703A1 HTLV-I AND HTLV-II gp21 DERIVED PEPTIDES FOR USE IN DIAGNOSTICS
11/22/1995EP0682702A1 Expression of protective antigens
11/22/1995EP0682697A1 Method and apparatus for anchorage and suspension cell culture
11/22/1995EP0682526A1 PULMONARY ADMINISTRATION OF sCR1 AND OTHER COMPLEMENT INHIBITORY PROTEINS
11/21/1995US5468636 Aphidicides
11/21/1995US5468635 In vitro method for stimulating cell growth by culturing cells in a serum-free culture medium comprising human lysozyme
11/21/1995US5468630 cDNA clone for human inducible nitric oxide synthase and process for preparing same
11/21/1995US5468615 Adding a compound to eukaryotic cell transformed with vector capable of expressing human dopamine receptor, assaying affinity of compound for receptor
11/21/1995US5468505 Local delivery of fibrinolysis enhancing agents
11/21/1995US5468468 Method for making a monoclonal antibody, monoclonal antibodies to α PD
11/21/1995CA1337597C Phosphinotricin-resistance gene, and its use
11/16/1995WO1995030763A2 Retroviral vectors having a reduced recombination rate
11/16/1995WO1995030758A1 Recombinant hk2 polypeptide
11/16/1995WO1995030753A1 CHIMERIC DELTA-ENDOTOXIN EXPRESSION IN $i(PSEUDOMONAS FLUORESCENS)
11/16/1995WO1995030752A1 IMPROVED BACILLUS THURINGIENSIS δ-ENDOTOXIN
11/16/1995WO1995030748A2 Plant u14 nucleic acid sequences and derivatives thereof
11/16/1995WO1995030742A1 Methods and compositions for the repair of articular cartilage defects in mammals
11/16/1995WO1995030693A1 Neurogenic differentiation (neurod) genes and proteins
11/16/1995WO1995030432A1 Use of chondroitin sulphate proteoglycans for protection of neurons
11/16/1995WO1995030428A1 Human dnase
11/16/1995WO1995030383A1 Methods and compositions for the repair of articular cartilage defects in mammals
11/16/1995WO1995018862A3 Tfda gene selectable markers in plants and the use thereof
11/16/1995EP0690919A4 Crucifer acc synthase and uses thereof
11/16/1995DE19517773A1 Rekombinante PRRSV-Proteine, Diagnostik-Kits und solche rekombinanten PRRSV-Proteine enthaltenden Vakzinen Recombinant PRRSV proteins, diagnostic kits and such recombinant PRRSV proteins containing vaccines
11/16/1995CA2189774A1 Recombinant hk2 polypeptide
11/16/1995CA2188795A1 Chimeric delta-endotoxin expression in pseudomonas fluorescens
11/16/1995CA2188450A1 Neurogenic differentiation (neurod) genes and proteins
11/16/1995CA2187534A1 Improved bacillus thuringiensis .delta.-endotoxin
11/16/1995CA2158977A1 Retroviral vectors having a reduced recombination rate
11/15/1995EP0682257A1 Methods of detecting collagen degradation in vivo
11/15/1995EP0682256A1 Methods of detecting collagen degradation in vivo
11/15/1995EP0682115A1 Synthetic insecticidal crystal protein gene
11/15/1995EP0682112A1 Method for archiving expression, or to improve the level of expression of a gene
11/15/1995EP0682111A1 Chimeric or transgenic animal and process for screening pharmaceutical products
11/15/1995EP0682110A1 Recombinant DNA encoding PDGF A-chain polypeptides
11/15/1995EP0682107A2 Method for the long term culturing of dermal papilla cells
11/15/1995EP0682106A2 Liver parenchymal cells having clonal growth ability, method for obtaining same, method for culturing same, and culturing system of primary hepatocytes
11/15/1995EP0682040A1 Humanized immunoglobulins and their production and use
11/15/1995EP0682039A1 CTLA4 molecules and IL4-binding molecules and uses thereof
11/15/1995EP0681846A2 Cell culture products
11/15/1995EP0681842A2 Ligand-mediated immunofunctional hormone binding protein assay method
11/15/1995EP0681614A1 Isolation of fetal erythrocytes
11/15/1995EP0681608A1 Therapeutic applications of chimeric organogenesis
11/15/1995EP0681585A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use
11/15/1995EP0681477A1 Genetic modification of neural stem cells
11/15/1995EP0681431A1 Production of human recombinant collagen in the milk of transgenic animals
11/15/1995EP0681427A1 Tomato spotted wilt virus
11/15/1995EP0618930A4 Monoclonal antibody to hiv-2 and uses thereof.
11/15/1995EP0448707B1 Bacteria harboring expression vectors encoding human CILIARY NEUROTROPHIC FACTOR (h-CNTF), their use in the production of h-CNTF, antibodies to h-CNTF and the use of h-CNTF in medical treatment
11/15/1995CN1111911A A method for producing taxol and taxanes from embryo cultures of taxus species
11/14/1995US5466676 Satellite cell proliferation in adult skeletal muscle
11/14/1995US5466597 Bacillus thuringiensis strains and their genes encoding insecticidal toxins
11/14/1995US5466596 Genetic engineering
11/14/1995US5466584 Oxytocin receptor and DNA coding therefor
11/14/1995US5466572 High speed flow cytometric separation of viable cells
11/09/1995WO1995030018A2 Recombinant poxviruses with foreign polynucleotides in essential regions
11/09/1995WO1995030014A1 Bifunctional protein, preparation and use
11/09/1995WO1995030008A1 Density enhanced protein tyrosine phosphatases
11/09/1995WO1995030007A1 Thymidine kinase mutants
11/09/1995WO1995030004A1 Monoclonal antibodies which promote central nervous system remyelination
11/09/1995WO1995030002A2 Enhancing the sensitivity of tumor cells to therapies
11/09/1995WO1995030000A1 Dna sequences
11/09/1995WO1995029993A1 Gene delivery vector using plasmid dna packaged into an adenovirus and a packaging cell line
11/09/1995WO1995029992A1 Method for purifying chromosomes and hybrid muntjac cell lines containing foreign chromosomes
11/09/1995WO1995029990A1 Immortalized and malignant human prostatic cell lines
11/09/1995WO1995029989A1 COMPOSITIONS AND METHOD OF STIMULATING THE PROLIFERATION AND DIFFERENTIATION OF HUMAN FETAL AND ADULT PANCREATIC CELLS $i(EX VIVO)
11/09/1995WO1995029988A1 In vitro growth of functional islets of langerhans and in vivo uses thereof
11/09/1995WO1995029987A1 Beta taipoxin as a cell growth factor and method
11/09/1995WO1995029935A1 Method for proliferating and differentiating b cells, and uses thereof
11/09/1995WO1995029933A1 Modified milk growth factor
11/09/1995WO1995029704A1 Cell lines obtained by in vivo migration and by fusion with autoimmune cells
11/09/1995WO1995029697A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995WO1995029696A1 Products of lacrimal gland for tear replacement
11/09/1995WO1995029693A1 Methods and compositions for modulating heterotypic e-cadherin interactions with t lymphocytes
11/09/1995WO1995029686A1 Recombinant fibrin chains, fibrin and fibrin-homologs
11/09/1995WO1995029667A1 Spin encapsulation apparatus and method of use
11/09/1995WO1995028166A3 Method for implanting encapsulated cells in a host
11/09/1995DE4441327C1 Embryonale Herzmuskelzellen, ihre Herstellung und ihre Verwendung Embryonic heart muscle cells, their preparation and their use
11/09/1995CA2690298A1 Methods and compositions for the treatment of glomerulonephritis and other inflammatory diseases
11/09/1995CA2537374A1 Density enhanced protein tyrosine phosphatases
11/09/1995CA2189543A1 Thymidine kinase mutants
11/09/1995CA2189438A1 Dna sequences
11/09/1995CA2189357A1 Beta taipoxin as a cell growth factor and method
1 ... 1705 1706 1707 1708 1709 1710 1711 1712 1713 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 ... 1827